Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Impetigo Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cephalosporins
1.2.3 Fusidane
1.2.4 Lincosamide Antibiotic
1.2.5 Penicillin
1.2.6 Penicillin-Like Antibiotics
1.2.7 Pleuromutilin
1.2.8 Pseudomonic Acid A
1.2.9 Quinolone
1.2.10 Sulfonamides And Folic Acid Inhibitors
1.2.11 Tetracyclines
1.3 Market by Application
1.3.1 Global Impetigo Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Impetigo Treatment Market Perspective (2018-2033)
2.2 Impetigo Treatment Growth Trends by Region
2.2.1 Global Impetigo Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Impetigo Treatment Historic Market Size by Region (2018-2023)
2.2.3 Impetigo Treatment Forecasted Market Size by Region (2024-2033)
2.3 Impetigo Treatment Market Dynamics
2.3.1 Impetigo Treatment Industry Trends
2.3.2 Impetigo Treatment Market Drivers
2.3.3 Impetigo Treatment Market Challenges
2.3.4 Impetigo Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Impetigo Treatment Players by Revenue
3.1.1 Global Top Impetigo Treatment Players by Revenue (2018-2023)
3.1.2 Global Impetigo Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Impetigo Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Impetigo Treatment Revenue
3.4 Global Impetigo Treatment Market Concentration Ratio
3.4.1 Global Impetigo Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Impetigo Treatment Revenue in 2022
3.5 Impetigo Treatment Key Players Head office and Area Served
3.6 Key Players Impetigo Treatment Product Solution and Service
3.7 Date of Enter into Impetigo Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Impetigo Treatment Breakdown Data by Type
4.1 Global Impetigo Treatment Historic Market Size by Type (2018-2023)
4.2 Global Impetigo Treatment Forecasted Market Size by Type (2024-2033)
5 Impetigo Treatment Breakdown Data by Application
5.1 Global Impetigo Treatment Historic Market Size by Application (2018-2023)
5.2 Global Impetigo Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Impetigo Treatment Market Size (2018-2033)
6.2 North America Impetigo Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Impetigo Treatment Market Size by Country (2018-2023)
6.4 North America Impetigo Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Impetigo Treatment Market Size (2018-2033)
7.2 Europe Impetigo Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Impetigo Treatment Market Size by Country (2018-2023)
7.4 Europe Impetigo Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Impetigo Treatment Market Size (2018-2033)
8.2 Asia-Pacific Impetigo Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Impetigo Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Impetigo Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Impetigo Treatment Market Size (2018-2033)
9.2 Latin America Impetigo Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Impetigo Treatment Market Size by Country (2018-2023)
9.4 Latin America Impetigo Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Impetigo Treatment Market Size (2018-2033)
10.2 Middle East & Africa Impetigo Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Impetigo Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Impetigo Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Detail
11.1.2 GlaxoSmithKline plc Business Overview
11.1.3 GlaxoSmithKline plc Impetigo Treatment Introduction
11.1.4 GlaxoSmithKline plc Revenue in Impetigo Treatment Business (2018-2023)
11.1.5 GlaxoSmithKline plc Recent Development
11.2 Karalex Pharma, LLC
11.2.1 Karalex Pharma, LLC Company Detail
11.2.2 Karalex Pharma, LLC Business Overview
11.2.3 Karalex Pharma, LLC Impetigo Treatment Introduction
11.2.4 Karalex Pharma, LLC Revenue in Impetigo Treatment Business (2018-2023)
11.2.5 Karalex Pharma, LLC Recent Development
11.3 Leo Pharma A/S
11.3.1 Leo Pharma A/S Company Detail
11.3.2 Leo Pharma A/S Business Overview
11.3.3 Leo Pharma A/S Impetigo Treatment Introduction
11.3.4 Leo Pharma A/S Revenue in Impetigo Treatment Business (2018-2023)
11.3.5 Leo Pharma A/S Recent Development
11.4 Lupin Limited
11.4.1 Lupin Limited Company Detail
11.4.2 Lupin Limited Business Overview
11.4.3 Lupin Limited Impetigo Treatment Introduction
11.4.4 Lupin Limited Revenue in Impetigo Treatment Business (2018-2023)
11.4.5 Lupin Limited Recent Development
11.5 NovaBay Pharmaceuticals, Inc.
11.5.1 NovaBay Pharmaceuticals, Inc. Company Detail
11.5.2 NovaBay Pharmaceuticals, Inc. Business Overview
11.5.3 NovaBay Pharmaceuticals, Inc. Impetigo Treatment Introduction
11.5.4 NovaBay Pharmaceuticals, Inc. Revenue in Impetigo Treatment Business (2018-2023)
11.5.5 NovaBay Pharmaceuticals, Inc. Recent Development
11.6 Pfizer, Inc.
11.6.1 Pfizer, Inc. Company Detail
11.6.2 Pfizer, Inc. Business Overview
11.6.3 Pfizer, Inc. Impetigo Treatment Introduction
11.6.4 Pfizer, Inc. Revenue in Impetigo Treatment Business (2018-2023)
11.6.5 Pfizer, Inc. Recent Development
11.7 Ranbaxy Laboratories Limited
11.7.1 Ranbaxy Laboratories Limited Company Detail
11.7.2 Ranbaxy Laboratories Limited Business Overview
11.7.3 Ranbaxy Laboratories Limited Impetigo Treatment Introduction
11.7.4 Ranbaxy Laboratories Limited Revenue in Impetigo Treatment Business (2018-2023)
11.7.5 Ranbaxy Laboratories Limited Recent Development
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Detail
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG Impetigo Treatment Introduction
11.8.4 Roche Holding AG Revenue in Impetigo Treatment Business (2018-2023)
11.8.5 Roche Holding AG Recent Development
11.9 SANDOZ GmbH
11.9.1 SANDOZ GmbH Company Detail
11.9.2 SANDOZ GmbH Business Overview
11.9.3 SANDOZ GmbH Impetigo Treatment Introduction
11.9.4 SANDOZ GmbH Revenue in Impetigo Treatment Business (2018-2023)
11.9.5 SANDOZ GmbH Recent Development
11.10 Taro Pharmaceutical Industries Ltd
11.10.1 Taro Pharmaceutical Industries Ltd Company Detail
11.10.2 Taro Pharmaceutical Industries Ltd Business Overview
11.10.3 Taro Pharmaceutical Industries Ltd Impetigo Treatment Introduction
11.10.4 Taro Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2018-2023)
11.10.5 Taro Pharmaceutical Industries Ltd Recent Development
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Detail
11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd Impetigo Treatment Introduction
11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2018-2023)
11.11.5 Teva Pharmaceutical Industries Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Impetigo Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cephalosporins
Table 3. Key Players of Fusidane
Table 4. Key Players of Lincosamide Antibiotic
Table 5. Key Players of Penicillin
Table 6. Key Players of Penicillin-Like Antibiotics
Table 7. Key Players of Pleuromutilin
Table 8. Key Players of Pseudomonic Acid A
Table 9. Key Players of Quinolone
Table 10. Key Players of Sulfonamides And Folic Acid Inhibitors
Table 11. Key Players of Tetracyclines
Table 12. Global Impetigo Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 13. Global Impetigo Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 14. Global Impetigo Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Impetigo Treatment Market Share by Region (2018-2023)
Table 16. Global Impetigo Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 17. Global Impetigo Treatment Market Share by Region (2024-2033)
Table 18. Impetigo Treatment Market Trends
Table 19. Impetigo Treatment Market Drivers
Table 20. Impetigo Treatment Market Challenges
Table 21. Impetigo Treatment Market Restraints
Table 22. Global Impetigo Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 23. Global Impetigo Treatment Market Share by Players (2018-2023)
Table 24. Global Top Impetigo Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Impetigo Treatment as of 2022)
Table 25. Ranking of Global Top Impetigo Treatment Companies by Revenue (US$ Million) in 2022
Table 26. Global 5 Largest Players Market Share by Impetigo Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Impetigo Treatment Product Solution and Service
Table 29. Date of Enter into Impetigo Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Impetigo Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 32. Global Impetigo Treatment Revenue Market Share by Type (2018-2023)
Table 33. Global Impetigo Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 34. Global Impetigo Treatment Revenue Market Share by Type (2024-2033)
Table 35. Global Impetigo Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 36. Global Impetigo Treatment Revenue Market Share by Application (2018-2023)
Table 37. Global Impetigo Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 38. Global Impetigo Treatment Revenue Market Share by Application (2024-2033)
Table 39. North America Impetigo Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. North America Impetigo Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Impetigo Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Impetigo Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Impetigo Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Impetigo Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Asia-Pacific Impetigo Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 46. Asia-Pacific Impetigo Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 47. Asia-Pacific Impetigo Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 48. Latin America Impetigo Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Latin America Impetigo Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 50. Latin America Impetigo Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 51. Middle East & Africa Impetigo Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 52. Middle East & Africa Impetigo Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 53. Middle East & Africa Impetigo Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 54. GlaxoSmithKline plc Company Detail
Table 55. GlaxoSmithKline plc Business Overview
Table 56. GlaxoSmithKline plc Impetigo Treatment Product
Table 57. GlaxoSmithKline plc Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 58. GlaxoSmithKline plc Recent Development
Table 59. Karalex Pharma, LLC Company Detail
Table 60. Karalex Pharma, LLC Business Overview
Table 61. Karalex Pharma, LLC Impetigo Treatment Product
Table 62. Karalex Pharma, LLC Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 63. Karalex Pharma, LLC Recent Development
Table 64. Leo Pharma A/S Company Detail
Table 65. Leo Pharma A/S Business Overview
Table 66. Leo Pharma A/S Impetigo Treatment Product
Table 67. Leo Pharma A/S Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 68. Leo Pharma A/S Recent Development
Table 69. Lupin Limited Company Detail
Table 70. Lupin Limited Business Overview
Table 71. Lupin Limited Impetigo Treatment Product
Table 72. Lupin Limited Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 73. Lupin Limited Recent Development
Table 74. NovaBay Pharmaceuticals, Inc. Company Detail
Table 75. NovaBay Pharmaceuticals, Inc. Business Overview
Table 76. NovaBay Pharmaceuticals, Inc. Impetigo Treatment Product
Table 77. NovaBay Pharmaceuticals, Inc. Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 78. NovaBay Pharmaceuticals, Inc. Recent Development
Table 79. Pfizer, Inc. Company Detail
Table 80. Pfizer, Inc. Business Overview
Table 81. Pfizer, Inc. Impetigo Treatment Product
Table 82. Pfizer, Inc. Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 83. Pfizer, Inc. Recent Development
Table 84. Ranbaxy Laboratories Limited Company Detail
Table 85. Ranbaxy Laboratories Limited Business Overview
Table 86. Ranbaxy Laboratories Limited Impetigo Treatment Product
Table 87. Ranbaxy Laboratories Limited Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 88. Ranbaxy Laboratories Limited Recent Development
Table 89. Roche Holding AG Company Detail
Table 90. Roche Holding AG Business Overview
Table 91. Roche Holding AG Impetigo Treatment Product
Table 92. Roche Holding AG Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 93. Roche Holding AG Recent Development
Table 94. SANDOZ GmbH Company Detail
Table 95. SANDOZ GmbH Business Overview
Table 96. SANDOZ GmbH Impetigo Treatment Product
Table 97. SANDOZ GmbH Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 98. SANDOZ GmbH Recent Development
Table 99. Taro Pharmaceutical Industries Ltd Company Detail
Table 100. Taro Pharmaceutical Industries Ltd Business Overview
Table 101. Taro Pharmaceutical Industries Ltd Impetigo Treatment Product
Table 102. Taro Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 103. Taro Pharmaceutical Industries Ltd Recent Development
Table 104. Teva Pharmaceutical Industries Ltd Company Detail
Table 105. Teva Pharmaceutical Industries Ltd Business Overview
Table 106. Teva Pharmaceutical Industries Ltd Impetigo Treatment Product
Table 107. Teva Pharmaceutical Industries Ltd Revenue in Impetigo Treatment Business (2018-2023) & (US$ Million)
Table 108. Teva Pharmaceutical Industries Ltd Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Impetigo Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Impetigo Treatment Market Share by Type: 2022 VS 2033
Figure 3. Cephalosporins Features
Figure 4. Fusidane Features
Figure 5. Lincosamide Antibiotic Features
Figure 6. Penicillin Features
Figure 7. Penicillin-Like Antibiotics Features
Figure 8. Pleuromutilin Features
Figure 9. Pseudomonic Acid A Features
Figure 10. Quinolone Features
Figure 11. Sulfonamides And Folic Acid Inhibitors Features
Figure 12. Tetracyclines Features
Figure 13. Global Impetigo Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 14. Global Impetigo Treatment Market Share by Application: 2022 VS 2033
Figure 15. Hospitals Case Studies
Figure 16. Clinic Case Studies
Figure 17. Others Case Studies
Figure 18. Impetigo Treatment Report Years Considered
Figure 19. Global Impetigo Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 20. Global Impetigo Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 21. Global Impetigo Treatment Market Share by Region: 2022 VS 2033
Figure 22. Global Impetigo Treatment Market Share by Players in 2022
Figure 23. Global Top Impetigo Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Impetigo Treatment as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by Impetigo Treatment Revenue in 2022
Figure 25. North America Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. North America Impetigo Treatment Market Share by Country (2018-2033)
Figure 27. United States Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Canada Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Europe Impetigo Treatment Market Share by Country (2018-2033)
Figure 31. Germany Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Asia-Pacific Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Asia-Pacific Impetigo Treatment Market Share by Region (2018-2033)
Figure 39. China Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Japan Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Southeast Asia Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. India Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Australia Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Latin America Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Latin America Impetigo Treatment Market Share by Country (2018-2033)
Figure 47. Mexico Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Brazil Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Impetigo Treatment Market Share by Country (2018-2033)
Figure 51. Turkey Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Impetigo Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. GlaxoSmithKline plc Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 54. Karalex Pharma, LLC Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 55. Leo Pharma A/S Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 56. Lupin Limited Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 57. NovaBay Pharmaceuticals, Inc. Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 58. Pfizer, Inc. Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 59. Ranbaxy Laboratories Limited Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 60. Roche Holding AG Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 61. SANDOZ GmbH Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 62. Taro Pharmaceutical Industries Ltd Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 63. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Impetigo Treatment Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed